Fibroblast growth factor 19 as a countermeasure to muscle and locomotion dysfunctions in experimental cerebral palsy

BACKGROUND: Cerebral palsy (CP) associates cerebral function damages with strong locomotor defects and premature sarcopenia. We previously showed that fibroblast growth factor 19 (FGF19) exerts hypertrophic effects on skeletal muscle and improves muscle mass and strength in mouse models with muscle...

Descripción completa

Detalles Bibliográficos
Autores principales: Pereira, Sabrina da Conceição, Benoit, Bérengère, de Aguiar Junior, Francisco Carlos Amanajás, Chanon, Stéphanie, Vieille‐Marchiset, Aurélie, Pesenti, Sandra, Ruzzin, Jérome, Vidal, Hubert, Toscano, Ana Elisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8718044/
https://www.ncbi.nlm.nih.gov/pubmed/34704398
http://dx.doi.org/10.1002/jcsm.12819

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8718044/
https://www.ncbi.nlm.nih.gov/pubmed/34704398
http://dx.doi.org/10.1002/jcsm.12819

Ejemplares similares